CTI BIOPHARMA CORP (CTIC)       5.72  -0.1 (-1.72%)

5.72  -0.1 (-1.72%)

US12648L6011 - Common Stock - After market: 5.72 0 (0%)

Buy % Consensus

Analysts have set a mean price target of 11.64. This target is 103.48% above the current price.
CTIC was analyzed by 15 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about CTIC.
In the previous month the buy percentage consensus was at a similar level.
CTIC was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 5.728.7910.2011.6415.75 - 53.62% 78.32% 103.48% 175.35%

Up and Down Grades

Date Firm Action Rating
2022-10-17 SVB Leerink Initiate Outperform
2022-09-01 JP Morgan Initiate Buy
2022-09-01 Jefferies Initiate Buy
2022-08-09 JMP Securities Maintains Market Outperform
2022-08-09 Needham Maintains Buy
2022-07-07 Cowen & Co. Initiate Outperform
2022-03-02 JMP Securities Maintains Market Outperform
2022-03-02 Needham Maintains Buy
2021-12-01 Needham Maintains Buy
2021-08-09 BTIG Initiate Buy
2021-05-06 Stifel Initiate Buy

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA